Prucalopride,Placebo

3 trials

Sponsors

Faculty of Medicine, Siriraj Hospital, Srinagarind Hospital Khonkaen University

Conditions

Must have provided written informed consent prior to any screening procedures. Male/female patients between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure. ERCPParkinson&#39Patients who were diagnosed as Parkinson&#39

Phase 3

Prucalopride for minimizing bowel ileus following ERCP with CO2 insufflation: A prospective randomize double-blinded placebo controlled trial

RecruitingTCTR20210814001

Srinagarind Hospital Khonkaen UniversityMust have provided written informed consent prior to any screening procedures. Male/female patients between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure. ERCP

Start: 2021-04-04Target: 194Updated: 2026-08-03

Phase 4

Role of Prucalopride treatment of chronic constipation in Parkinson disease

Active, not recruitingTCTR20200211001

Faculty of Medicine, Siriraj HospitalPatients who were diagnosed as Parkinson&#39

Start: 2020-02-19Target: 80Updated: 2026-08-03

Unknown Phase

Efficacy of prucalopride for improving motor fluctuations in patients with Parkinsonâ€™s disease

Active, not recruitingTCTR20180808002

Start: 2018-08-15Target: 30Updated: 2026-08-03